BioSpace News Archive

Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotech company, is pleased to provide the following shareholder letter.

Partnership will enable expansion of proprietary vision correction platform into new therapeutic, diagnostic and telehealth applications

Vivante Health, the leader in digital medicine for gut health and disease, proudly announced DebraAnn Braun has joined the company as Chief Technology Officer.

Deep Genomics, the leading artificial intelligence (AI) therapeutics company, announced today the closing of its Series B round with $40 million in new investment

Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company pioneering a new way to treat the underlying cause of severe genetic diseases by precisely upregulating protein expression, today announced that Chief Executive Officer Edward M. Kaye, M.D., will present at the 38th Annual J.P. Morgan Healthcare Conference

Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional therapeutics, today announced that management will present a corporate overview and updated clinical development plans for its lead candidates ZW25 and ZW49 at the upcoming 38th Annual J.P. Morgan Healthcare Conference

Boundless Bio, a company interrogating and targeting extrachromosomal DNA (ecDNA) in aggressive cancers, today announced presentations at the following upcoming conferences

Interim Assessment Anticipated in Second Half of 2020

Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced an oral presentation at the 2020 NASH-TAG Conference being held on January 9-11, 2020 in Park City, Utah.

Spearhead Lodge (SHL) formally announced today that as the complexity of our world increases, they are changing to meet that need